Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07311928 · ClinicalTrials.gov registry record · NA
HELIOS: Human Embryo Illumination to Enhance Development
A NA study of IVF Outcomes, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT07311928 is a NA study of IVF Outcomes that is actively recruiting participants, run by Columbia University. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07311928, a NA study of IVF Outcomes, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Embryos need a lot of energy to grow, but as women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for embryos to develop normally. One possible way to help is with a gentle light treatment called photobiomodulation (PBM). This uses a special type of red light that boosts energy production in cells and helps them stay healthy. This study will test whether adding this light treatment during in vitro fertilization (IVF) can improve embryo growth and pregnancy chances.
Conditions Studied
Interventions
- OTHER Photobiomodulation
Study Locations (1)
New York
- Columbia University Fertility Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07311928
The ClinicalTrials.gov registry entry for NCT07311928 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with IVF Outcomes appearing as the primary indexed condition, and to 1 intervention - of which Photobiomodulation is the first listed.
NCT07311928 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07311928 about?
NCT07311928 is a clinical study titled "HELIOS: Human Embryo Illumination to Enhance Development". Embryos need a lot of energy to grow, but as women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for embryos to develop normally. One possible way to help is with a gentle light treatment called photobiomodulation (PBM). This uses a special...
What is the current status of trial NCT07311928?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-12-03. Estimated completion is 2028-06-01.
What conditions does trial NCT07311928 study?
This clinical trial studies the following conditions: IVF Outcomes.
What interventions are being tested in trial NCT07311928?
The interventions under investigation include: Photobiomodulation (OTHER).
Who is sponsoring clinical trial NCT07311928?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07311928 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.